Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119347) titled 'An early clinical study evaluating the tolerance, safety and efficacy of VGN-Ex05e-001 in patients with autism spectrum disorder who have severe and refractory self-harm/assault behaviors' on Feb. 26.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine
Condition:
ASD patients with Severe Self-Injurious / Aggression Behaviours
Intervention:
Experimental group 1:Stereotactic intracerebral injection of VGN-Ex05e solution into the nucleus accumbens, with 2.0x10^6 cells
Recruitment Status: Not Recruitin...